Resultados de la búsqueda 11-20 of 9934 for prostate cancer
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a ...
The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...
Many of the current imaging tests we have for prostate cancer are problematic in their ability to distinguish cancerous from non-cancerous prostate tissue.
De Mayo Clinic a tu buzón ... Inscríbete gratis y mantente al día en cuanto a avances en las investigaciones, consejos sobre salud, temas médicos de actualidad y ...
2022; doi:10.1016/j.ucl.2022.01.001. Prostate cancer early stage. National Comprehensive Cancer Network. https://www.nccn.org/patientresources/patient-resources ...
Prostate cancer treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq ...
A Study to Detect Prostate Cancer Extraprostatic Extension with Slip Interface Imaging Determined Tumor Slip Length ... prostate cancers. Financial ...
... prostate cancer. The objectives are to describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer internationally; to ...
A Study to Detect Prostate Cancer Extraprostatic Extension with Slip Interface Imaging Determined Tumor Slip Length. Rochester, Minn. The purpose of this ...
Living with cáncer de próstata en estadio 4? Connect with others like you for support and answers to your questions in the Prostate Cancer support group on Mayo ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?